Non-Small Cell Lung Cancer with KRAS G12C Mutation
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer diagnoses globally. It includes subtypes such as adenocarcinoma, squamous cell carcinoma, and…
KRAS G12C drugs